Forward and reverse pharmacology approaches in drug discovery: Figure 3
Atanas G. Atanasov(University of Vienna), Hermann Stuppner(Universität Innsbruck), Verena M. Dirsch(University of Vienna), Eva‐Maria Pferschy‐Wenzig(University of Graz), Rudolf Bauer(University of Graz), Stefan Schwaiger(Universität Innsbruck), Christoph Wawrosch(University of Vienna), Thomas Linder(TU Wien), Birgit Waltenberger(Universität Innsbruck), Pavel Uhrín(Medical University of Vienna), Judith M. Rollinger(University of Vienna), Veronika Temml(Universität Innsbruck), Johannes M. Breuss(Medical University of Vienna), Elke H. Heiß(University of Vienna), Limei Wang(Wuhan Polytechnic University), Valery Bochkov(Medical University of Vienna), Daniela Schuster(Trinity College Dublin), Brigitte Kopp(University of Vienna), Marko D. Mihovilovič(Rutherford Appleton Laboratory)
Unknown
January 1, 2015
Cited by 0
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Discovery and resupply of pharmacologically active plant-derived natural products: A review
|Biotechnology Advances|2015|2.9k
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review
|Biochemical Pharmacology|2014|593
Phytol: A review of biomedical activities
|Food and Chemical Toxicology|2018|476